A new algorithm uses a statistical approach to critical process parameter assessment, allowing for faster, more consistent, and less subjective critical process parameter quantification, visualization, and documentation.
Fangfang Liu
Advertisement
Fangfang Liu, PhD, is manager of Pfizer’s department of pharmaceutical science and manufacturing statistics.
Articles by Fangfang Liu
Advertisement
Latest Updated Articles
Removing Subjectivity from the Assessment of Critical Process Parameters and Their ImpactPublished: January 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
3
Standardizing Operations to Meet Global Sustainability and Resilience Goals
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
